NERx Biosciences, Inc.

Biotechnology company · Indianapolis, Indiana, United States

NERx Biosciences, Inc. is a biotechnology company headquartered in Indianapolis, Indiana, United States. It has received 6 US government small-business research awards (SBIR/STTR) from health agencies, $3.4 million in total, most recently in 2024. It has reported private securities offerings to the US SEC, most recently $200,000 sold in a notice filed in 2021.

www.nerxbiosciences.comProfile compiled from public records. Is this your company? Request a correction or update

NERx Biosciences at a glance

Typebiotechnology company
HeadquartersIndianapolis, Indiana, United States
Employees (self-reported, 2024)2
SEC CIK1764454

What does NERx Biosciences do?

US government research funding

6 SBIR/STTR small-business research awards from US health agencies, $3.4 million in total (2012 to 2024). NIH funding came from the National Cancer Institute, National Institute of General Medical Sciences.

Private fundraising reported to the SEC

2 Form D notices; the most recent reported $200,000 sold (2021).

Frequently asked questions about NERx Biosciences

Where is NERx Biosciences headquartered?

NERx Biosciences, Inc. is headquartered in Indianapolis, Indiana, United States.

What does NERx Biosciences do?

NERx Biosciences, Inc. is a biotechnology company.

Similar companies

Need a CRO or CDMO for your next study?

Compare transparent quotes from research and manufacturing partners, then contract once. Free for buyers.

Compare quotes

Last updated 2026-09-23. Data licences